Predictive Oncology Inc. is at the forefront of revolutionizing medicine through AI-driven biomarker and drug discovery for precision health. With a vast biobank of diverse live-cell tumor specimens, the company is uniquely positioned to drive long-term value and shape the future of cancer treatment and drug development. Collaborating with UPMC Magee-Womens Hospital, Predictive Oncology developed […]
Tag: biomarker discovery
Revolutionizing Medicine with AI-Driven Biomarker Discovery
Predictive Oncology Inc. is at the forefront of revolutionizing medicine through AI-driven biomarker and drug discovery for precision health. With a vast biobank of diverse live-cell tumor specimens, the company is uniquely positioned to drive long-term value and shape the future of cancer treatment and drug development. Collaborating with UPMC Magee-Womens Hospital, Predictive Oncology developed […]
University of Houston Secures Funding for Cancer Biomarker Facility Launch
In a groundbreaking development, the University of Houston has secured $3M to establish a state-of-the-art Cancer Immunotherapy Biomarker Core facility. This cutting-edge facility is set to revolutionize biomarker discovery, enhance immunotherapy targeting, and bolster research capabilities throughout Texas. By boosting the state’s standing in cancer research, this initiative promises to drive advancements in patient outcomes […]